Because higher EpCAM expression was observed in FRO and ACT-1 in vitro analyses, the expression of EpCAM was examined by immunohistochemistry in clinical thyroid cancer specimens (Figure 7A and B). This evidence concerns the gene TRAF3IP2 and thyroid cancer.